Pediatric chronic urticaria: Clinical and laboratory characteristics and factors linked to remission.
CIndU
CSU
angioedema
basophil activation test
chronic urticaria
eosinophils
pediatric
Journal
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
06
01
2023
received:
05
08
2022
accepted:
13
02
2023
medline:
29
3
2023
entrez:
28
3
2023
pubmed:
29
3
2023
Statut:
ppublish
Résumé
Chronic urticaria (CU) is defined as the occurrence of wheals/angioedema for ≥6 consecutive weeks. Until now, guidelines and publications addressing CU have focused mainly on adults. As a result, evidence and guidance in the pediatric population are scarce. This study aims to describe clinical and laboratory findings in pediatric CU and to determine factors associated with remission. 185 patients, 54% female, median age at onset of 8.8 years. Angioedema was present in almost half. The most common type of CU was chronic spontaneous urticaria (CSU) in 74%. At least one atopic comorbidity was found in almost a third (35%). In addition, 8% had an autoimmune disorder (exclusively in CSU) and 9% had a psychiatric condition. Basopenia was found in 67% and was more frequently associated with CSU. The basophil activation test (BAT) was positive in 40%. With regard to remission, being of male sex, angioedema absence, the absence of physical triggers, and eosinophil counts >0.51 × 10 Atopy is a common condition in pediatric CU. CSU is the most common type. Autoimmune comorbidities and basopenia were significantly more common in CSU. In addition, ours is one of the few studies, assessing BAT utility in the pediatric population, being positive in a relevant percentage (40%). BAT positivity was more frequent in CSU. Our results suggest that the absence of angioedema and physical triggers, male sex, and eosinophil counts >0.51 × 10
Sections du résumé
BACKGROUND
Chronic urticaria (CU) is defined as the occurrence of wheals/angioedema for ≥6 consecutive weeks. Until now, guidelines and publications addressing CU have focused mainly on adults. As a result, evidence and guidance in the pediatric population are scarce.
METHODS
This study aims to describe clinical and laboratory findings in pediatric CU and to determine factors associated with remission.
RESULTS
185 patients, 54% female, median age at onset of 8.8 years. Angioedema was present in almost half. The most common type of CU was chronic spontaneous urticaria (CSU) in 74%. At least one atopic comorbidity was found in almost a third (35%). In addition, 8% had an autoimmune disorder (exclusively in CSU) and 9% had a psychiatric condition. Basopenia was found in 67% and was more frequently associated with CSU. The basophil activation test (BAT) was positive in 40%. With regard to remission, being of male sex, angioedema absence, the absence of physical triggers, and eosinophil counts >0.51 × 10
CONCLUSION
Atopy is a common condition in pediatric CU. CSU is the most common type. Autoimmune comorbidities and basopenia were significantly more common in CSU. In addition, ours is one of the few studies, assessing BAT utility in the pediatric population, being positive in a relevant percentage (40%). BAT positivity was more frequent in CSU. Our results suggest that the absence of angioedema and physical triggers, male sex, and eosinophil counts >0.51 × 10
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13929Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393-1414. doi:10.1111/all.13397
Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy. 2020;75(2):423-432. doi:10.1111/all.14037
Lara-Corrales I, Balma-Mena A, Pope E. Chronic urticaria in children. Clin Pediatr (Phila). 2009;48(4):351-355. doi:10.1177/0009922808328543
Kim H, Hyun MC, Choi BS. Natural history and influencing factors of chronic urticaria in children. Allergy Asthma Immunol Res. 2022;14(1):73-84.
Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011;66(3):317-330. doi:10.1111/j.1398-9995.2010.02496.x
Sahiner UM, Civelek E, Tuncer A, et al. Chronic urticaria: etiology and natural course in children. Int Arch of Allergy and Immunol. 2011;156(2):224-230. doi:10.1159/000322349
Kolkhir P, Church MK, Altrichter S, et al. Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity, and poor response to treatment. J Allergy Clin Immunol Pract. 2020;8(1):318-325.e5. doi:10.1016/j.jaip.2019.08.025
Chansakulporn S, Pongpreuksa S, Sangacharoenkit P, et al. The natural history of chronic urticaria in childhood: a prospective study. J Am Acad Dermatol. 2014;71(4):663-668. doi:10.1016/j.jaad.2014.05.069
Jirapongsananuruk O, Pongpreuksa S, Sangacharoenkit P, Visitsunthorn N, Vichyanond P. Identification of the etiologies of chronic urticaria in children: a prospective study of 94 patients. Pediatr Allergy Immunol. 2010;21(3):508-514. doi:10.1111/j.1399-3038.2009.00912.x
Lachover-Roth I, Rabie A, Cohen-Engler A, Rosman Y, Meir-Shafrir K, Confino-Cohen R. Chronic urticaria in children - new insights from a large cohort. Pediatr Allergy Immunol. 2021;32(5):999-1005. doi:10.1111/pai.13457
Cortellazzo Wiel L, Conversano E, Giangreco M, et al. Natural history and predictors of recovery in children with chronic spontaneous urticaria. Pediatr Allergy Immunol. 2021;32(1):201-204. doi:10.1111/pai.13299
Netchiporouk E, Sasseville D, Moreau L, Habel Y, Rahme E, Ben-Shoshan M. Evaluating comorbidities, natural history, and predictors of early resolution in a cohort of children with chronic urticaria. JAMA Dermatol. 2017;153(12):1236-1242. doi:10.1001/jamadermatol.2017.3182
Kolkhir P, Metz M, Altrichter S, Maurer M. Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: a systematic review. Allergy. 2017;72(10):1440-1460. doi:10.1111/all.13182
Konstantinou GN, Konstantinou GN. Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis. Clin Transl Allergy. 2019;9:42. doi:10.1186/s13601-019-0278-3
Cornillier H, Giraudeau B, Munck S, et al. Chronic spontaneous urticaria in children - a systematic review on interventions and comorbidities. Pediatr Allergy Immunol. 2018;29(3):303-310. doi:10.1111/pai.12870
Kolkhir P, Borzova E, Grattan C, Asero R, Pogorelov D, Maurer M. Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review. Autoimmun Rev. 2017;16(12):1196-1208. doi:10.1016/j.autrev.2017.10.003
Tzur Bitan D, Berzin D, Cohen A. The association of chronic spontaneous urticaria (CSU) with anxiety and depression: a nationwide cohort study. Arch Dermatol Res. 2021;313(1):33-39. doi:10.1007/s00403-020-02064-3
Hergüner S, Kiliç G, Karakoç S, Tamay Z, Tüzün Ü, Güler N. Levels of depression, anxiety and behavioural problems and frequency of psychiatric disorders in children with chronic idiopathic urticaria. Br J Dermatol. 2011;164(6):1342-1347. doi:10.1111/J.1365-2133.2010.10138.X
Sánchez J, Amaya E, Acevedo A, Celis A, Caraballo D, Cardona R. Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: associated risk factors. J Allergy Clin Immunol Pract. 2017;5(2):464-470. doi:10.1016/j.jaip.2016.09.029
Miles LM, Gabrielli S, Le M, et al. Clinical characteristics, management, and natural history of chronic inducible urticaria in a pediatric cohort. Int Arch Allergy Immunol. 2021;182(8):757-764. doi:10.1159/000514757
Asero R, Cugno M. Biomarkers of chronic spontaneous urticaria and their clinical implications. Expert Rev Clin Immunol. 2021;17(3):247-254. doi:10.1080/1744666X.2021.1882304
Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy. 2004;59(8):869-873. doi:10.1111/J.1398-9995.2004.00473.X
Gregoriou S, Rigopoulos D, Katsambas A, et al. Etiologic Aspects and Prognostic Factors of Patients with Chronic Urticaria: Nonrandomized, Prospective, Descriptive Study. Journal of Cutaneous Medicine and Surgery 2009;13(4):198-203. doi:10.2310/7750.2008.08035
Ferrer M. Immunological events in chronic spontaneous urticaria. Clin Transl Allergy. 2015;5:30. doi:10.1186/s13601-015-0074-7
Grattan CEH, Dawn G, Gibbs S, Francis DM. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy. 2003;33(3):337-341. doi:10.1046/j.1365-2222.2003.01589.x
Konstantinou GN, Asero R, Ferrer M, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy. 2013;68(1):27-36. doi:10.1111/all.12056
Schoepke N, Asero R, Ellrich A, et al. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: results of the PURIST study. Allergy. 2019;74(12):2427-2436. doi:10.1111/all.13949
Marcelino J, Baumann K, Skov PS, et al. What basophil testing tells us about CSU patients - results of the CORSA study. Front Immunol. 2021;12:742470. doi:10.3389/fimmu.2021.742470
Brunetti L, Francavilla R, Miniello VL, et al. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol. 2004;114(4):922-927. doi:10.1016/j.jaci.2004.07.042
Netchiporouk E, Moreau L, Rahme E, Maurer M, Lejtenyi D, Ben-Shoshan M. Positive CD63 basophil activation tests are common in children with chronic spontaneous urticaria and linked to high disease activity. Int Arch Allergy Immunol. 2016;171(2):81-88. doi:10.1159/000451084
D'Auria E, de Amici M, Licari A, et al. Basophil activation test in children with autoimmune chronic spontaneous urticaria: is it ready for clinical practice? Immunobiology. 2019;224(1):30-33. doi:10.1016/j.imbio.2018.11.001